Beijing Leadman Biochemistry Co Ltd
Beijing Leadman Biochemistry Co.,Ltd. researches and develops, manufactures, and sells vitro diagnostic reagents and instruments, and biochemical raw materials in the People's Republic of China. The company offers biochemical raw materials, including enzymes, antigens, coenzymes, antibodies, buffers, enzyme substrates, culture mediums, stain agents, amino acids, and other products for biotechnolo… Read more
Beijing Leadman Biochemistry Co Ltd (300289) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.007x
Based on the latest financial reports, Beijing Leadman Biochemistry Co Ltd (300289) has a cash flow conversion efficiency ratio of 0.007x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥11.89 Million) by net assets (CN¥1.71 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Beijing Leadman Biochemistry Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Beijing Leadman Biochemistry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Beijing Leadman Biochemistry Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beijing Leadman Biochemistry Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Korea Line
KO:005880
|
0.039x |
|
Abacus Group
AU:ABG
|
0.026x |
|
Ranger Energy Services Inc
NYSE:RNGR
|
0.050x |
|
Energiekontor AG
F:EKT
|
-0.007x |
|
FocalTech Systems Co Ltd
TW:3545
|
0.063x |
|
Everjoy Health Group Co Ltd
SHE:002162
|
0.048x |
|
Allied Blenders & Distillers Ltd
NSE:ABDL
|
N/A |
|
Samhyun
KQ:437730
|
0.029x |
Annual Cash Flow Conversion Efficiency for Beijing Leadman Biochemistry Co Ltd (2008–2024)
The table below shows the annual cash flow conversion efficiency of Beijing Leadman Biochemistry Co Ltd from 2008 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.72 Billion | CN¥62.41 Million | 0.036x | -51.25% |
| 2023-12-31 | CN¥1.80 Billion | CN¥134.42 Million | 0.074x | +21.74% |
| 2022-12-31 | CN¥1.78 Billion | CN¥108.93 Million | 0.061x | +1.65% |
| 2021-12-31 | CN¥1.98 Billion | CN¥119.06 Million | 0.060x | -38.79% |
| 2020-12-31 | CN¥1.38 Billion | CN¥135.56 Million | 0.098x | +14.38% |
| 2019-12-31 | CN¥1.45 Billion | CN¥124.65 Million | 0.086x | +52.52% |
| 2018-12-31 | CN¥1.44 Billion | CN¥81.02 Million | 0.056x | -33.59% |
| 2017-12-31 | CN¥1.43 Billion | CN¥120.97 Million | 0.085x | +38.74% |
| 2016-12-31 | CN¥1.34 Billion | CN¥81.78 Million | 0.061x | -56.65% |
| 2015-12-31 | CN¥1.26 Billion | CN¥177.82 Million | 0.141x | +1267.55% |
| 2014-12-31 | CN¥1.09 Billion | CN¥-13.21 Million | -0.012x | -111.38% |
| 2013-12-31 | CN¥851.12 Million | CN¥90.45 Million | 0.106x | +39.78% |
| 2012-12-31 | CN¥761.02 Million | CN¥57.86 Million | 0.076x | -42.81% |
| 2011-12-31 | CN¥220.77 Million | CN¥29.34 Million | 0.133x | -60.29% |
| 2010-12-31 | CN¥159.72 Million | CN¥53.46 Million | 0.335x | +12.77% |
| 2009-12-31 | CN¥105.32 Million | CN¥31.26 Million | 0.297x | +13.30% |
| 2008-12-31 | CN¥83.90 Million | CN¥21.98 Million | 0.262x | -- |